MAIA: MAIA Biotechnology Inc Net earnings per share (EPS TTM)

MAIA Biotechnology, Inc. (MAIA) - corporate logo

MAIA Biotechnology develops targeted cancer immunotherapy and is currently in a high-expenditure phase with no current revenue. Patient safety is ensured through strict adherence to temperature controls during drug delivery. The rolling net income per share snapshot demonstrates financial stability, where the value of -0.48 characterizes this level. Business development relies on scientific and clinical alliances with medical centers without acquisitions.

MAIA MAIA Biotechnology Net earnings per share for the last 12 months (04/28/2023 - 11/12/2026)

Summary analytical data breakdowns for MAIA Biotech (MAIA)

- share price and expert price forecast:
Stock Quotes MAIA Biotechnology|MAIA - Fair Value Consensus
- market capitalization information:
Market Capitalization MAIA Biotechnology, Inc.|MAIA - Company Buyout Price
- business book valuation details:
Net Assets per Single Share MAIA Biotechnology|MAIA - Company Net Assets|Market Value to Book Value Ratio MAIABiotech.com|MAIA - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio MAIA Biotechnology|MAIA - Long-Term Debt to Capital|Short-Term Debt to Equity MAIA Biotechnology Inc|MAIA - Company Aggregate Debt|Debt to Book Capitalization Ratio MAIA Biotechnology, Inc.|MAIA - Long-Term Debt|Company Current Liabilities MAIA Biotechnology|Quick Liquidity Indicator MAIABiotech.com
- earnings and multiples data:
MAIA - Profit After Payment of Taxes|Projected Future Earnings MAIA Biotechnology|MAIA - Company Value to Net Income|Forward P/E Multiple MAIA Biotechnology, Inc.|MAIA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MAIA Biotechnology, Inc.|MAIA - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) MAIA Biotechnology|MAIA - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months MAIABiotech.com|MAIA - Earnings per share trend in current year|Expected earnings per share growth for next year MAIA Biotechnology
Fundamental valuation:MAIA - MAIA Biotechnology
Flagship merchandise of MAIA Biotechnology Inc

MAIA Biotechnology (MAIA) developments in immuno-oncology remain independent of economic cycles and macro shocks. Analyzing the annual net income per share trend allows for an assessment of the business's intrinsic value. This metric compares the final financial result with the volume of securities issued. This enables the identification of the balance between asset supply and institutional capital demand. The price action of this line serves as a filter to exclude loss-making strategies.

Main competitors

IBRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMCR (immunocore.com)|JANX: Net earnings per share (EPS TTM)|RCUS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Zymeworks Corp|Net earnings per share for the last 12 months Tango Therapeutics Corp (TNGX)|Earnings per share for the last twelve months Iovance Biotherapeutics (IOVA)|Net earnings per share for the last 12 months immatics.com IMTX|Xencor - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Compass Therapeutics Inc CMPX|REPL - Earnings per share for the last twelve months|LYEL (Lyell Pharma) - Earnings per share for the last 12 months|Innate Pharma S.A. (IPHA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Pyxis Oncology (PYXS)|Net earnings per share for the last 12 months CGEN|IOBT - Net earnings per share for the trailing year|Net earnings per share for the last 12 months STRO (Sutro Bio)|Earnings per share for the last four quarters INKT|Net earnings per share (EPS TTM) HOWL (Werewolf Therapeutics, Inc.)|Earnings per share for the trailing year IMMX|ALX Oncology Holdings - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months cuebiopharma.com|pdsbiotech.com (PDSB) - Earnings per share for the last twelve months|Sonnet BioTherapeutics Holdings - Earnings per share for the trailing year|LIMN (Liminatus Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Lava Tx|Earnings per share for the last twelve months NextCure (NXTC)|LPTX: Earnings per one share for the last 12 months|Intensity Therapeutics, Inc. - Net earnings per share for the last 12 months|Sensei Biotherapeutics Inc (SNSE) - Net earnings per one share for the last twelve months|TOVX - Earnings per share for the last twelve months|Gritstone bio, Inc. (GRTS) - Net earnings per share for the last 12 months|KA: Net earnings per share (EPS TTM)|NexImmune Inc (NEXI) - Net earnings per share (EPS TTM)|TSBX (Turnstone Biologics Corp) - Net earnings per share (EPS TTM)|Vaccinex Inc (VCNX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HARP